BACKGROUND: Angiogenesis can be enhanced by several growth factors, like vascular endothelial growth factor-165 (VEGF(165)) and basic fibroblast growth factor (bFGF). Delayed release of such growth factors could be provided by incorporation of growth factors in fibrin matrices. In this study, we present a slow release system for VEGF(165) and bFGF in fibrin sealant. MATERIALS AND METHODS: In vitro: Pieces of Integratrade mark matrix of 15 mm in diameter were prepared. Integratrade mark matrices were divided into four groups (A=control; B=fibrin sealant; C=fibrin sealant+growth factors; D=growth factors). In vivo: The bioartificial dermal templates were transplanted into a full-skin defect of the back of nu-nu mice. Four different groups included each six matrices at 2 and 4 weeks. RESULTS: In vitro: In groups C and D, continuous release of VEGF(165) and bFGF was eminent. The incorporation of growth factors into fibrin sealant evoked a prolonged growth factor release (p < 0.05). In vivo: A significantly higher amount of vessels was quantified in groups C and D compared to groups A and B (p < 0.001). CONCLUSIONS: A model of slow protein release by combining VEGF(165) and bFGF with fibrin sealant was produced. This model resulted in a prolonged bioavailability of growth factors in vivo for functional purposes. Fibrin and collagen can release growth factors in vivo and induce significant and faster neovascularisation in bioartificial dermal templates.
BACKGROUND: Angiogenesis can be enhanced by several growth factors, like vascular endothelial growth factor-165 (VEGF(165)) and basic fibroblast growth factor (bFGF). Delayed release of such growth factors could be provided by incorporation of growth factors in fibrin matrices. In this study, we present a slow release system for VEGF(165) and bFGF in fibrin sealant. MATERIALS AND METHODS: In vitro: Pieces of Integratrade mark matrix of 15 mm in diameter were prepared. Integratrade mark matrices were divided into four groups (A=control; B=fibrin sealant; C=fibrin sealant+growth factors; D=growth factors). In vivo: The bioartificial dermal templates were transplanted into a full-skin defect of the back of nu-nu mice. Four different groups included each six matrices at 2 and 4 weeks. RESULTS: In vitro: In groups C and D, continuous release of VEGF(165) and bFGF was eminent. The incorporation of growth factors into fibrin sealant evoked a prolonged growth factor release (p < 0.05). In vivo: A significantly higher amount of vessels was quantified in groups C and D compared to groups A and B (p < 0.001). CONCLUSIONS: A model of slow protein release by combining VEGF(165) and bFGF with fibrin sealant was produced. This model resulted in a prolonged bioavailability of growth factors in vivo for functional purposes. Fibrin and collagen can release growth factors in vivo and induce significant and faster neovascularisation in bioartificial dermal templates.
Authors: H G Machens; S Grzybowski; B Bucsky; T Spanholtz; C Niedworok; A Maichle; B Stöckelhuber; A Condurache; F Liu; J T Egana; M Kaun; P Mailänder; T Aach Journal: J Surg Res Date: 2005-11-07 Impact factor: 2.192
Authors: Renhai Cao; Ebba Bråkenhielm; Robert Pawliuk; David Wariaro; Mark J Post; Eric Wahlberg; Philippe Leboulch; Yihai Cao Journal: Nat Med Date: 2003-03-31 Impact factor: 53.440
Authors: Y Tsurumi; S Takeshita; D Chen; M Kearney; S T Rossow; J Passeri; J R Horowitz; J F Symes; J M Isner Journal: Circulation Date: 1996-12-15 Impact factor: 29.690
Authors: M Shou; V Thirumurti; S Rajanayagam; D F Lazarous; E Hodge; J A Stiber; M Pettiford; E Elliott; S M Shah; E F Unger Journal: J Am Coll Cardiol Date: 1997-04 Impact factor: 24.094
Authors: P Koolwijk; M G van Erck; W J de Vree; M A Vermeer; H A Weich; R Hanemaaijer; V W van Hinsbergh Journal: J Cell Biol Date: 1996-03 Impact factor: 10.539
Authors: Karyn G Robinson; Ting Nie; Aaron D Baldwin; Elaine C Yang; Kristi L Kiick; Robert E Akins Journal: J Biomed Mater Res A Date: 2012-02-28 Impact factor: 4.396
Authors: Alan J Man; Gregory Kujawski; Travis S Burns; Elaine N Miller; Fernando A Fierro; J Kent Leach; Peter Bannerman Journal: Cell Mol Bioeng Date: 2016-01-13 Impact factor: 2.321
Authors: Ken Matsuda; Katrina J Falkenberg; Alan A Woods; Yu Suk Choi; Wayne A Morrison; Rodney J Dilley Journal: Tissue Eng Part A Date: 2013-03-28 Impact factor: 3.845
Authors: Thilo L Schenck; Myra N Chávez; Alexandru P Condurache; Ursula Hopfner; Farid Rezaeian; Hans-Günther Machens; José T Egaña Journal: J Vis Exp Date: 2014-08-28 Impact factor: 1.355
Authors: Ritsuko Sawada; Carrie Y Peterson; Ana Maria Gonzalez; Bruce M Potenza; Barbara Mueller; Raul Coimbra; Brian P Eliceiri; Andrew Baird Journal: Fibrogenesis Tissue Repair Date: 2011-02-17
Authors: A Arkudas; J Tjiawi; A Saumweber; J P Beier; E Polykandriotis; O Bleiziffer; R E Horch; U Kneser Journal: J Cell Mol Med Date: 2008-06-28 Impact factor: 5.310